Growth Metrics

Healthstream (HSTM) Cash & Current Investments (2016 - 2026)

Healthstream has reported Cash & Current Investments over the past 16 years, most recently at $57.0 million for Q4 2025.

  • Quarterly Cash & Current Investments fell 41.36% to $57.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57.0 million through Dec 2025, down 41.36% year-over-year, with the annual reading at $57.0 million for FY2025, 41.36% down from the prior year.
  • Cash & Current Investments was $57.0 million for Q4 2025 at Healthstream, down from $92.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $113.3 million in Q1 2025 and troughed at $39.2 million in Q2 2022.
  • The 5-year median for Cash & Current Investments is $59.6 million (2021), against an average of $69.2 million.
  • Year-over-year, Cash & Current Investments plummeted 60.59% in 2021 and then surged 48.31% in 2024.
  • A 5-year view of Cash & Current Investments shows it stood at $51.9 million in 2021, then grew by 3.78% to $53.9 million in 2022, then soared by 31.95% to $71.1 million in 2023, then soared by 36.67% to $97.2 million in 2024, then plummeted by 41.36% to $57.0 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Cash & Current Investments are $57.0 million (Q4 2025), $92.6 million (Q3 2025), and $90.6 million (Q2 2025).